Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms

Table 1 Patients’ baseline characteristics

	Overall	SIBO (n = 12)	no-SIBO (n = 27)	P value
Age	53 (41-60)	55 (41-60)	57 (43-60)	0.306
Sex (males/females)	14 (35.9)/25 (64.1)	2 (16.7)/10 (83.3)	12 (44.4)/15 (55.6)	0.095
Vitamin K2 intake (μg/d)	29.5 (8-103.6)	21.2 (8-49.7)	31.9 (10.5-103.6)	0.111
	Males: 25.7 (8-103.6)
	Females 29.6 (10.4-91.8)
Framingham risk score	5.4 (2-8)	5.5 (2-7)	5.2 (2-8)	0.897
	Males: 5.8 (2-8)
	Females: 6.9 (0-8)

Data are expressed as median (range) or frequency (%). Comparisons have been performed between SIBO and no-SIBO group. Framingham score was built on age, sex, race, arterial pressure, smoking, diabetes, total blood cholesterol, HDL-cholesterol. SIBO: Small intestinal bacterial overgrowth.